Guide

Sterile vs Bacteriostatic Water: What Changes After the Seal Is Broken

Sterile water for injection and bacteriostatic water for injection are both pharmaceutical-grade diluents used to reconstitute lyophilized peptides. At the point of manufacture they appear nearly identical — both are sterile, both are regulated by the FDA, and both serve as solvents for dissolving dry powder into a liquid solution. The critical difference emerges after the vial is opened: sterile water contains no preservative and is strictly single-use, while bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth and permits multi-dose use within a 28-day window. Choosing the wrong diluent for a multi-dose peptide preparation can introduce bacterial contamination that the preservative was designed to prevent. This guide explains the regulatory classification of each product, how they differ in composition and in-use handling, and when each is appropriate in a laboratory reconstitution context.

What Is Sterile Water for Injection?

Sterile Water for Injection (SWFI) is a pharmaceutical-grade diluent containing only sterile water — no preservative, no antimicrobial agent, and no added buffer. It is manufactured under FDA oversight, defined by a USP monograph, and supplied in single-dose vials. Because it contains no bacteriostatic agent, once the vial's seal is broken (the rubber stopper is punctured with a needle), the solution is exposed to whatever microorganisms are present in the surrounding environment. With no preservative to inhibit growth, any bacteria introduced during entry can multiply rapidly at room temperature. For this reason, FDA labeling for Sterile Water for Injection explicitly states that the vial is intended for single-use only and that any remaining contents must be discarded after the first entry. SWFI is not a multi-dose product.

Key points

• Sterile Water for Injection contains only sterile water — no preservative, no benzyl alcohol, no antimicrobial agent.
• It is supplied in single-dose vials. Once punctured, the contents must be used immediately and any remainder discarded.
• FDA drug labeling explicitly designates it as single-dose, single-use after opening.
• Without a preservative, any bacteria introduced at the point of entry can multiply unchecked at room temperature.
• SWFI is defined by a USP monograph and manufactured under cGMP (Current Good Manufacturing Practice) requirements, the same quality framework as bacteriostatic water — the difference is composition, not manufacturing standard.

What Is Bacteriostatic Water for Injection?

Bacteriostatic Water for Injection is sterile water that contains 0.9% benzyl alcohol (9 mg/mL) as a bacteriostatic preservative. The term 'bacteriostatic' means the preservative inhibits the growth and reproduction of bacteria — it does not actively kill bacteria already present (that would be 'bactericidal'). The benzyl alcohol addresses the contamination risk that arises whenever a vial is punctured with a needle and re-entered over time. Because of the preservative, the FDA-approved drug label for Bacteriostatic Water for Injection designates it as a multi-dose vial: it can be punctured and drawn from multiple times within a limited in-use window, typically 28 days from first entry. Like SWFI, it is manufactured under FDA oversight, defined by a USP monograph, and produced under cGMP. The only compositional difference between the two products is the addition of benzyl alcohol.

Key points

• Bacteriostatic Water for Injection contains 0.9% (9 mg/mL) benzyl alcohol as a bacteriostatic preservative.
• 'Bacteriostatic' means it inhibits bacterial growth — it does not sterilize an already-contaminated solution.
• The preservative allows the vial to be punctured multiple times within a 28-day in-use window after first entry.
• It is FDA-regulated, USP-monograph-defined, and manufactured under cGMP — the same quality framework as sterile water.
• The sole compositional difference from sterile water is the addition of benzyl alcohol.

Side-by-Side Comparison

The table below summarizes the differences between Sterile Water for Injection and Bacteriostatic Water for Injection. Both products are sterile at the point of manufacture, both are FDA-regulated pharmaceutical products, and both are defined by USP monographs. The differences are in preservative content, in-use classification, and the handling window after the vial is first opened.

Key points

• Composition: Sterile water = water only. Bacteriostatic water = water + 0.9% benzyl alcohol.
• FDA label classification: Sterile water = single-dose vial. Bacteriostatic water = multi-dose vial.
• In-use window after first puncture: Sterile water = use immediately, discard remainder. Bacteriostatic water = 28 days per CDC multi-dose vial guidance.
• Preservative: Sterile water = none. Bacteriostatic water = benzyl alcohol (bacteriostatic, not bactericidal).
• Regulatory framework: Both are FDA-regulated drug products with USP monographs and cGMP manufacturing — the difference is formulation, not regulatory tier.
• Neonate contraindication: Bacteriostatic water is contraindicated in neonates due to benzyl alcohol toxicity risk (gasping syndrome). Sterile water has no such contraindication.

Why the Distinction Matters for Peptide Reconstitution

Lyophilized peptides are supplied as dry powder and must be reconstituted with a liquid diluent before use. The reconstituted solution is typically drawn from the vial over multiple sessions — not consumed in a single use. Each time a needle punctures the rubber stopper, there is a risk of introducing environmental bacteria into the vial. With plain sterile water, there is no preservative to inhibit the growth of any bacteria introduced. At room temperature, a contaminated, preservative-free solution can support rapid microbial proliferation. With bacteriostatic water, the benzyl alcohol inhibits bacterial growth between draws, providing a window of safe multi-dose use. This is why USP <797>, which governs sterile compounding, recognizes bacteriostatic water for injection as an appropriate diluent for multi-dose compounded preparations. Using sterile water to reconstitute a peptide intended for multi-dose use would provide no protection against post-opening contamination — the single most important practical reason the distinction between the two diluents matters in a reconstitution context.

Key points

• Reconstituted peptides are typically drawn from the vial over multiple sessions, not used in a single entry.
• Each needle puncture risks introducing environmental bacteria into the vial.
• Plain sterile water has no preservative — any bacteria introduced can multiply rapidly at room temperature.
• Bacteriostatic water's benzyl alcohol inhibits bacterial growth between draws, enabling safe multi-dose use within 28 days.
• USP <797> sterile compounding standards recognize bacteriostatic water for injection as appropriate for multi-dose compounded preparations.
• Using sterile water for a multi-dose peptide preparation would provide no antimicrobial protection after the first puncture.

FDA Regulatory Classification of Each Product

Both Sterile Water for Injection and Bacteriostatic Water for Injection are FDA-regulated pharmaceutical drug products, not dietary supplements, cosmetics, or research chemicals. Each has an approved FDA drug label (e.g., the Hospira/Pfizer labels), is defined by a USP monograph that specifies composition, sterility, and quality standards, and is manufactured under cGMP requirements. The FDA classifies them differently in one respect: the single-dose versus multi-dose designation on the drug label. Sterile Water for Injection is labeled as a single-dose vial — the FDA label states that the unused portion must be discarded after the vial is entered. Bacteriostatic Water for Injection is labeled as a multi-dose vial — the label permits multiple entries within the in-use window, reflecting the preservative's protective function. Products sold online as 'sterile water' or 'bacteriostatic water' without FDA registration may not meet USP monograph standards for sterility, preservative concentration, or manufacturing quality, and may carry quality and safety risks not present in pharmaceutical-grade product.

Key points

• Both products are FDA-regulated drug products with approved drug labels and USP monograph definitions.
• Sterile Water for Injection is labeled as a single-dose vial — the FDA label requires discard of any remainder after first entry.
• Bacteriostatic Water for Injection is labeled as a multi-dose vial — the FDA label permits multiple entries within the in-use window.
• Both are manufactured under cGMP — the regulatory difference is the label classification (single-dose vs. multi-dose), not the manufacturing quality tier.
• Unregistered products sold online as 'sterile water' or 'bacteriostatic water' may not meet USP monograph standards and may carry sterility and safety risks.

When to Use Each Diluent (Lab Context)

In a laboratory reconstitution context, the choice between sterile water and bacteriostatic water depends on how the reconstituted solution will be used. If the entire reconstituted solution will be used in a single session — the vial will be drawn from once and any remainder discarded — plain sterile water is sufficient and avoids unnecessary exposure to benzyl alcohol. This may be appropriate for analytical work where a single aliquot is prepared for immediate HPLC or mass spectrometry analysis, or where the peptide is known to be sensitive to benzyl alcohol. If the solution will be stored and drawn from over multiple sessions — as is common with multi-dose peptide preparations — bacteriostatic water is the appropriate diluent because the preservative inhibits bacterial growth between uses. Some peptides are sensitive to benzyl alcohol or require alternative solvents (e.g., acetic acid for acidic peptides, DMSO for hydrophobic peptides); in those cases, plain sterile water or a specific buffer is used, and the solution must be treated as single-use regardless. The choice of diluent is a chemistry and handling decision, not a dosing decision. This guide does not provide instructions for how much solution to draw or how to administer it.

Key points

• Single-session use: plain sterile water is sufficient and avoids unnecessary benzyl alcohol exposure.
• Multi-session use: bacteriostatic water is appropriate because the preservative inhibits bacterial growth between draws.
• Benzyl alcohol-sensitive peptides: use plain sterile water or a specific buffer and treat the solution as single-use.
• Analytical work (HPLC, MS): solvent choice is dictated by instrument compatibility and peptide chemistry, not by the multi-dose question.
• Solvent selection is a chemistry and handling decision — this guide provides no dosing, volume, or administration guidance.

Related pages